Background Radiofrequency ablation (RFA) has been used to treat hepatocellular
carcinoma (HCC) and liver metastases for more than 10 years with promising early …

Background A soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4 (sCTLA‐4) is a prognostic
biomarker for several cancers but remains unclear in HCC patients. The aim of study is to …

OBJECTIVE. This study was designed to assess whether artificial ascites has a heat-sink
effect on the ablation zone for percutaneous radiofrequency ablation (RFA) of hepatic …

Radiofrequency ablation (RFA) has been used as a curative therapy for small hepatocellular
carcinoma (HCC). However, relatively little is known about the long-term outcome of RFA for …

Background The risk factors for recurrence and death after radiofrequency ablation (RFA) for
hepatocellular carcinoma (HCC) remain poorly known. This study was aimed to study the 10 …

Purpose The purpose of the study was to prospectively evaluate safety and effectiveness of
percutaneous microwave ablation under temperature monitoring assisted with ethanol …

Image-guided percutaneous thermal ablation is increasingly utilized in the treatment of
hepatic malignancies. Peripherally located hepatic tumors can be difficult to access or …

Current guidelines advocate percutaneous radiofrequency (RF) ablation as a standard
treatment of early stage hepatocellular carcinoma (HCC) for up to three tumors≤ 3 cm in …

OBJECTIVE. The aim of our study was to evaluate the value of 3D registration images
reconstructed by fusion of pre-and posttreatment CT or MRI for the assessment of ablative …

The management of hepatic metastases from colorectal cancer (HMCRC) is multimodal
including chemotherapy, surgical resection, radiation therapy, and focused destruction …